Powered to cure
diabetic foot disease
from within

Triovance uses cell & gene therapy to accelerate wound healing with the only therapeutic solution that cures diabetic foot disease at the source.

Learn more about our science

Why Triovance?

Developing the Potential To CURE Diabetic Foot Ulcers

A low-cost, non-invasive, scalable solution for outpatient care. If approved, TRV-01 represents the only therapeutic solution that cures diabetic foot disease at the source.

Our Science

TRV-01 is the first-and-only skin graft technology that cures diabetic foot disease from within by treating the root causes of disease including increased angiogenesis and decreased cellular glycation of growth factor receptors.

Learn more



Our Team

Backed by a leadership team with years of experience bringing innovative biotech products to market, along with the most renowned scientific advisory board, Triovance has the expertise to succeed.

Learn more



Recent News

Triovance is proud to announce its selection as one of the finalists in the highly competitive INCIDE Booster Program, which aims to accelerate the development of innovative companies and academic institutions in the life sciences sector.

Learn more



Our Science

Learn more



Our Team

Backed by a leadership team with years of experience bringing innovative biotech products to market, along with the most renowned scientific advisory board, Triovance has the expertise to succeed.

Learn more



Recent News

Learn more



About us

Meet the Team

Our mission is to improve the quality of life of patients with chronic-degenerative diseases such as diabetes with products based ontissue engineering, gene therapy, and cell therapy.

CEO & Founder

Blanca Segura, PhD

Founder

Jaime Cervantes

Executive Director

Ian Wisenberg

Newsroom

News & articles

Stay up to date on our latest breakthroughs, product advancements, press releases and more.

Browse all articles

Triovance to Present Novel Treatment for Diabetic Foot Disease and Company Update at Biotech Showcase 2025

TRV-01 is the only technology designed to address the root causes of diabetic foot disease.

Triovance Presents Diabetic Foot Disease Treatment to Investors at INCIDE Pharma & Health Tech Booster Program Demo Day

Triovance, one of eight private company finalists in the highly competitive.

Get in touch



Thank you! We’ll get back to you soon

We have received your message and will get back to you as soon as possible. Our team is dedicated to providing the best support and we appreciate your patience.

Oops! Something went wrong.